Methods for treating mucopolysaccharidosis
US-2024374534-A1 · Nov 14, 2024 · US
Uses of lipophenolic compounds
US11419841B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11419841-B2 |
| Application number | US-201816762739-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 12, 2018 |
| Priority date | Nov 10, 2017 |
| Publication date | Aug 23, 2022 |
| Grant date | Aug 23, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to compound of formula (I):whereinR is O—R3 orR1 and R2 are identical or different and are each independently H, (C1-C6)alkyl, —CO—(C1-C21)alkyl or —CO—(C11-C21)alkenyl group, provided that at least one of R1 or R2 is H or (C1-C6)alkyl,R3 is a —CO—(C11-C21)alkyl or —CO—(C11-C21)alkenyl group,or its pharmaceutically acceptable salts, racemates, diastereoisomers, enantiomers, or mixtures thereof,for use in prevention and/or treatment of a disease or disorder linked to an exacerbated vascular, lymphatic or mucosal permeability.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of encephalitis comprising administering, to a person in need thereof, a compound of formula (IIb): with R 3 selected from the group consisting of: or its pharmaceutically acceptable salts, racemates, diastereoisomers, enantiomers, or mixtures thereof. 2. The method of claim 1 , wherein the compound is administered for 1 to 4 days, and just before and/or during the acute phase response associated with factors inducing the increased vascular, lymphatic or mucosal permeability. 3. The method of claim 1 , wherein the compound of formula (IIb) is administered in association with at least one additional active compound selected from the group consisting of antibiotic, antiviral, antifungal, antiparasitic, anti-inflammatory active compound and mixtures thereof.
Assignees
Inventors
Classifications
having three or more double bonds, e.g. etretinate · CPC title
- A61K31/235Primary
having an aromatic ring attached to a carboxyl group · CPC title
- A61K31/23Primary
of acids having a carboxyl group bound to a chain of seven or more carbon atoms · CPC title
Monocarboxylic acid esters having at least two carbon-to-carbon double bonds · CPC title
having three or more carbon atoms in the acid moiety · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11419841B2 cover?
- The present invention relates to compound of formula (I):whereinR is O—R3 orR1 and R2 are identical or different and are each independently H, (C1-C6)alkyl, —CO—(C1-C21)alkyl or —CO—(C11-C21)alkenyl group, provided that at least one of R1 or R2 is H or (C1-C6)alkyl,R3 is a —CO—(C11-C21)alkyl or —CO—(C11-C21)alkenyl group,or its pharmaceutically acceptable salts, racemates, diastereoisomers, ena…
- Who is the assignee on this patent?
- Univ Montpellier, Centre Nat Rech Scient, Ecole Nat Superieure De Chimie, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/235. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).